Compare · MO vs NAII
MO vs NAII
Side-by-side comparison of Altria Group Inc. (MO) and Natural Alternatives International Inc. (NAII): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MO and NAII operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- MO is the larger of the two at $113.66B, about 8346.7x NAII ($13.6M).
- MO has hit the wire 2 times in the past 4 weeks while NAII has been quiet.
- MO has more recent analyst coverage (21 ratings vs 0 for NAII).
- Company
- Altria Group Inc.
- Natural Alternatives International Inc.
- Price
- $68.81+1.08%
- $2.26+9.71%
- Market cap
- $113.66B
- $13.6M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 2
- 0
- Recent ratings
- 21
- 0
Altria Group Inc.
Altria Group, Inc., through its subsidiaries, manufactures and sells cigarettes, oral tobacco products, and wine in the United States. It offers cigarettes primarily under the Marlboro brand; cigars principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. The company also produces and sells varietal and blended table wines, and sparkling wines under the Chateau Ste. Michelle and 14 Hands names; and imports and markets Antinori, Torres, and Villa Maria Estate wines, as well as Champagne Nicolas Feuillatte in the United States. In addition, it provides finance leasing services primarily in transportation, power generation, real estate, and manufacturing equipment industries. The company sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.
Natural Alternatives International Inc.
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Asia, and internationally. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
Latest MO
- Altria Announces Arrangement with Philip Morris International to Enhance Operational Efficiency
- Philip Morris International Announces Contract Manufacturing Collaboration with Altria
- SEC Form 10-Q filed by Altria Group Inc.
- Altria Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Altria Reports 2026 Second-Quarter and First-Half Results; Narrows 2026 Full-Year Earnings Guidance
- Cadiz Inc. Announces CFO Succession
- BTIG Research initiated coverage on Altria
- Altria to Host Webcast of 2026 Second-Quarter and First-Half Results
- UBS reiterated coverage on Altria with a new price target
- SEC Form 11-K filed by Altria Group Inc.
Latest NAII
- SEC Form S-8 filed by Natural Alternatives International Inc.
- SEC Form 10-Q filed by Natural Alternatives International Inc.
- SEC Form NT 10-Q filed by Natural Alternatives International Inc.
- CarnoSyn® Brands Expands TriBsyn® Applications Across Beverage, Dairy, and Medical Nutrition
- Natural Alternatives International Inc. filed SEC Form 8-K: Leadership Update
- CarnoSyn® Brands Launches CarnoSyn® 4X, a Next-Generation Beta-Alanine for Sports Performance
- Natural Alternatives International Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 4 filed by Natural Alternatives International Inc.
- SEC Form 4 filed by Natural Alternatives International Inc.
- President, COO, & Sec. Wolf Kenneth covered exercise/tax liability with 5,151 shares and was granted 15,000 shares, increasing direct ownership by 7% to 141,831 units (SEC Form 4)